文献速递糖尿病

2型糖尿病患者肾移植的长期结局:一项人群队列研究

Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-01-01

这项人群队列研究纳入1994年1月1日至2012年12月31日澳大利亚和新西兰透析与移植登记的全部初次肾移植受者,比较糖尿病与非糖尿病受者的结局。985例(9%)患2型糖尿病,其全因死亡和带功能移植物死亡的校正风险更高,年轻受者风险最高,且随移植年代无改善。

要点

  • 糖尿病患者肾移植后前10年死亡率高于非糖尿病受者。
  • 糖尿病患者全因死亡校正HR为1.60,带功能移植物死亡HR为1.54。
  • 糖尿病状态与年龄存在交互作用,小于40岁受者风险最高。

核心结论

  • 2型糖尿病肾移植受者生存率显著较差,5年死亡率超过非糖尿病受者的两倍以上。
  • 糖尿病受者生存劣势在年龄小于40岁者中最大。
  • 与普通人群不同,2型糖尿病肾移植后死亡率随时间无改善证据。

研究设计与样本

  • 人群队列研究,纳入澳大利亚和新西兰透析与移植登记中1994年1月1日至2012年12月31日的所有初次肾移植受者。

主要发现

  • 共纳入10714例肾移植受者,其中985例(9%)患有2型糖尿病。
  • 糖尿病患者移植后前10年死亡率为每100例受者25.3例,非糖尿病受者为每100例受者11.5例。
  • 糖尿病患者全因死亡的校正HR为1.60(95%CI 1.37-1.86;p<0.0001),带功能移植物死亡的校正HR为1.54(95%CI 1.28-1.85;p<0.0001)。
  • 年龄小于40岁的糖尿病受者全因死亡校正HR为5.16(95%CI 2.84-9.35;p<0.0001),带功能移植物死亡校正HR为9.83(95%CI 4.51-21.43;p<0.0001)。
  • 年龄大于55岁的糖尿病受者全因死亡校正HR为1.41(95%CI 1.17-1.71;p=0.002),带功能移植物死亡校正HR为1.27(95%CI 1.02-1.59;p=0.03)。

关键数值与推荐

  • 糖尿病状态与全因死亡和带功能移植物死亡的关联受受者年龄修饰(交互作用p<0.0001)。
  • 移植年代未修饰糖尿病状态与死亡率之间的关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Overall survival for younger patients with type 2 diabetes without kidney disease has improved substantially over time, but whether a similar pattern of improvement is observed in diabetic kidney transplant recipients remained uncertain. We aimed to compare patient outcomes between diabetic and non-diabetic transplant recipients, and to determine the effect of age and era on patient survival. METHODS: This population cohort study included all primary kidney-only transplant recipients included in the Australia and New Zealand Dialysis and Transplant registry between Jan 1, 1994, and Dec 31, 2012. The primary outcomes were all-cause mortality and death with functioning graft. Associations between outcomes and diabetes status were examined using adjusted Cox regression, and interactions between diabetes status and transplant era and recipient age were examined. FINDINGS: Of 10 714 transplant recipients, 985 (9%) had type 2 diabetes. Mortality rates in the first 10 years after transplantation were higher in recipients with diabetes (25·3 per 100 recipients) compared to those without diabetes (11·5 per 100 recipients). Compared with recipients without diabetes, the adjusted hazard ratios (HR) for all-cause mortality and death with a functioning graft in recipients with diabetes were 1·60 (95% CI 1·37-1·86; p<0·0001) and 1·54 (1·28-1·85 p<0·0001), respectively. The association between diabetes status, all-cause mortality, and death with a functioning graft was modified by recipient age (pinteraction<0·0001), with the highest risk in recipients with diabetes aged younger than 40 years (adjusted HR 5·16 [95% CI 2·84-9·35], p<0·0001; and 9·83 [4·51-21·43], p<0·0001; for all-cause mortality and death with a functioning graft, respectively). Risk was increased to a lesser extent in recipients with diabetes aged older than 55 years (adjusted HR 1·41 [95% CI 1·17-1·71; p=0·002] and 1·27 [1·02-1·59; p=0·03], for all-cause mortality and death with a functioning graft, respectively). Transplant era did not modify the association between diabetes status and mortality. INTERPRETATION: Kidney transplant recipients with type 2 diabetes had substantially poorer patient survival, with 5-year mortality rates exceeding those for non-diabetic recipients by over two times. The magnitude of this survival disadvantage was greatest in recipients with diabetes aged less than 40 years. By contrast with the general population, there was no evidence of improvement in mortality over time among people with type 2 diabetes following kidney transplantation. FUNDING: None.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Lim WH, Wong G, Pilmore HL, et al. Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. Lancet Diabetes Endocrinol. 2017. PMID: 28010785. doi:10.1016/S2213-8587(16)30317-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。